Nrf2 has been proved as an important target for the treatment of neurodegenerative diseases, respiratory diseases, digestive diseases, cardiovascular diseases, metabolic diseases and cardiovascular diseases. This evidence concerns the gene NFE2L2 and cardiovascular disorder.